IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 714 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease
Amrana Qureshi,Banu Kaya,Shivan Pancham,Russell Keenan,Jeremy Anderson,Magbor Akanni,Jo Howard
British Journal of Haematology.2018;181(4)460
[DOI]
2Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease
Thamal Darshana,David Rees,Anuja Premawardhena
Orphanet Journal of Rare Diseases.2021;16(1)460
[DOI]
3Hydroxyurea-induced palmar-plantar erythrodysesthesia in an adult with sickle cell disease
Ramandeep K. Bambrah,Fauzia Rana,Dat C. Pham
Community Oncology.2011;8(5)237
[DOI]
4Efficacy of fixed low dose hydroxyurea in Indian children with sickle cell anemia: A single centre experience
Dipti L. Jain,Mohini Apte,Roshan Colah,Vijaya Sarathi,Saumil Desai,Amruta Gokhale,Amol Bhandarwar,Harshwardhan L. Jain,Kanjaksha Ghosh
Indian Pediatrics.2013;50(10)929
[DOI]
5Sickle cell disease in India
Roshan Colah,Malay Mukherjee,Kanjaksha Ghosh
Current Opinion in Hematology.2014;21(3)215
[DOI]
6Sickle cell disease in India: a scoping review from a health systems perspective to identify an agenda for research and action
Vineet Raman,Tanya Seshadri,Sangeetha V Joice,Prashanth N Srinivas
BMJ Global Health.2021;6(2)e004322
[DOI]
7Comprehensive integrated care for patients with sickle cell disease in a remote aboriginal tribal population in southern India
Vivek Nimgaonkar,Lakshmanan Krishnamurti,Hari Prabhakar,Nandakumar Menon
Pediatric Blood & Cancer.2014;61(4)702
[DOI]
8Enhancing Effect of Hydroxyurea on Hb F in Sickle Cell Disease: Ten-Year Egyptian Experience
Ilham Youssry,Amina Abdel-Salam,Rania Ismail,Rayan Bou-Fakhredin,Rania Mohamed Samy,Fatma Ezz El-Deen,Ali T. Taher
Hemoglobin.2017;41(4-6)267
[DOI]
9Low Fixed-Dose Hydroxyurea in Severely Affected Indian Children with Sickle Cell Disease
Dipty L. Jain,Vijaya Sarathi,Saumil Desai,Manoj Bhatnagar,Abhijit Lodha
Hemoglobin.2012;36(4)323
[DOI]
10Hydroxyurea Treatment in Transfusion-Dependent -Thalassemia Patients
Mohammad Reza Bordbar,Samir Silavizadeh,Sezaneh Haghpanah,Roza Kamfiroozi,Marzieh Bardestani,Mehran Karimi
Iranian Red Crescent Medical Journal.2014;16(6)323
[DOI]
11Hydroxyurea-associated acral erythema in a patient with polycythemia vera
Daniel Butler,Vinod E. Nambudiri,Tina Nandi
American Journal of Hematology.2014;89(9)931
[DOI]
12Unlocking the Binding and Reaction Mechanism of Hydroxyurea Substrates as Biological Nitric Oxide Donors
Sai Lakshmana Vankayala,Jacqueline C. Hargis,H. Lee Woodcock
Journal of Chemical Information and Modeling.2012;52(5)1288
[DOI]
13Clinical manifestations of sickle cell disease in India
Dipty Jain,Dipika Mohanty
Current Opinion in Hematology.2018;25(3)171
[DOI]
14Update on the use of hydroxyurea therapy in sickle cell disease
Trisha E. Wong,Amanda M. Brandow,Wendy Lim,Richard Lottenberg
Blood.2014;124(26)3850
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow